Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Stock Price Prediction
Update at 5:00pm EST
1.952 - 1.96
1.96 - 1.967
1.732 - 1.74
1.74 - 1.748
1.856 - 1.869
1.869 - 1.883
as of: 2019-10-23 4:52:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.MRSN has closed above the upper band by 1.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 32.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Warning: file_get_contents(https://cloud.iexapis.com/stable/stock/MRSN/news/last/2?token=pk_bbca652777ff4f0390283f6278a13274): failed to open stream: HTTP request failed! HTTP/1.1 402 Payment Required
in /home/content/81/11032181/html/www/stoxline/quote.php on line 283
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.